These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus. Béquet F, Uzabiaga F, Desbazeille M, Ludwiczak P, Maftouh M, Picard C, Scatton B, Le Fur G. Eur J Neurosci; 2007 Dec 30; 26(12):3458-64. PubMed ID: 18052990 [Abstract] [Full Text] [Related]
3. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon. Mulè F, Amato A, Baldassano S, Serio R. Pharmacol Res; 2007 Aug 30; 56(2):132-9. PubMed ID: 17574859 [Abstract] [Full Text] [Related]
4. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System. Lisboa SF, Gomes FV, Silva AL, Uliana DL, Camargo LH, Guimarães FS, Cunha FQ, Joca SR, Resstel LB. Int J Neuropsychopharmacol; 2015 Jan 24; 18(8):. PubMed ID: 25618404 [Abstract] [Full Text] [Related]
5. Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice. Naderi N, Haghparast A, Saber-Tehrani A, Rezaii N, Alizadeh AM, Khani A, Motamedi F. Pharmacol Biochem Behav; 2008 Mar 24; 89(1):64-75. PubMed ID: 18096213 [Abstract] [Full Text] [Related]
6. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD. Fidelman S, Mizrachi Zer-Aviv T, Lange R, Hillard CJ, Akirav I. Eur Neuropsychopharmacol; 2018 May 24; 28(5):630-642. PubMed ID: 29519609 [Abstract] [Full Text] [Related]
7. Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats. Ho WS, Gardiner SM. Br J Pharmacol; 2009 Jan 24; 156(1):94-104. PubMed ID: 19133994 [Abstract] [Full Text] [Related]
8. Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice. Naderi N, Aziz Ahari F, Shafaghi B, Najarkolaei AH, Motamedi F. J Neural Transm (Vienna); 2008 Nov 24; 115(11):1501-11. PubMed ID: 18575801 [Abstract] [Full Text] [Related]
9. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations. Mulè F, Amato A, Baldassano S, Serio R. Pharmacol Res; 2007 Sep 24; 56(3):185-92. PubMed ID: 17656103 [Abstract] [Full Text] [Related]
10. Cannabinoid receptor agonists potentiate action potential-independent release of GABA in the dentate gyrus through a CB1 receptor-independent mechanism. Hofmann ME, Bhatia C, Frazier CJ. J Physiol; 2011 Aug 01; 589(Pt 15):3801-21. PubMed ID: 21646412 [Abstract] [Full Text] [Related]
11. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition. Scherma M, Medalie J, Fratta W, Vadivel SK, Makriyannis A, Piomelli D, Mikics E, Haller J, Yasar S, Tanda G, Goldberg SR. Neuropharmacology; 2008 Jan 01; 54(1):129-40. PubMed ID: 17904589 [Abstract] [Full Text] [Related]
12. Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice. Umathe SN, Manna SS, Jain NS. Behav Brain Res; 2011 Sep 30; 223(1):125-34. PubMed ID: 21549765 [Abstract] [Full Text] [Related]
13. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats. Viana TG, Hott SC, Resstel LB, Aguiar DC, Moreira FA. Psychopharmacology (Berl); 2015 May 30; 232(9):1545-53. PubMed ID: 25388290 [Abstract] [Full Text] [Related]
14. Enhancing Endocannabinoid Neurotransmission Augments The Efficacy of Extinction Training and Ameliorates Traumatic Stress-Induced Behavioral Alterations in Rats. Morena M, Berardi A, Colucci P, Palmery M, Trezza V, Hill MN, Campolongo P. Neuropsychopharmacology; 2018 May 30; 43(6):1284-1296. PubMed ID: 29265107 [Abstract] [Full Text] [Related]
15. Endocannabinoid analogues exacerbate marble-burying behavior in mice via TRPV1 receptor. Umathe SN, Manna SS, Jain NS. Neuropharmacology; 2012 Apr 30; 62(5-6):2024-33. PubMed ID: 22248639 [Abstract] [Full Text] [Related]
16. Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity. Hampson RE, Miller F, Palchik G, Deadwyler SA. Neuropharmacology; 2011 May 30; 60(6):944-52. PubMed ID: 21288475 [Abstract] [Full Text] [Related]
17. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats. Hasanein P, Teimuri Far M. Pharmacol Biochem Behav; 2015 Apr 30; 131():130-5. PubMed ID: 25689415 [Abstract] [Full Text] [Related]
18. Cannabinoids prevent the differential long-term effects of exposure to severe stress on hippocampal- and amygdala-dependent memory and plasticity. Shoshan N, Segev A, Abush H, Mizrachi Zer-Aviv T, Akirav I. Hippocampus; 2017 Oct 30; 27(10):1093-1109. PubMed ID: 28667676 [Abstract] [Full Text] [Related]
19. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats. Forget B, Guranda M, Gamaleddin I, Goldberg SR, Le Foll B. Psychopharmacology (Berl); 2016 May 30; 233(10):1823-8. PubMed ID: 26864774 [Abstract] [Full Text] [Related]
20. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Kim J, Alger BE. Nat Neurosci; 2010 May 30; 13(5):592-600. PubMed ID: 20348918 [Abstract] [Full Text] [Related] Page: [Next] [New Search]